MarkWide Research

Sale!

Direct-to-Consumer (DTC) Genetic Testing Market Analysis- Industry Size, Share, Research Report, Insights, Covid-19 Impact, Statistics, Trends, Growth and Forecast 2022-2030

Published Date: October, 2022
No of Pages: 159
Delivery Format: PDF+Excel

$2,950.00

Direct-to-Consumer Genetic Testing Market size surpassed USD 1.4 billion in 2021 and is expected to witness 15.3% CAGR from 2022 to 2028. Growing prevalence of rare genetic diseases is expected to drive the market growth. Rising demand for personalized care for genetic services as well as rising public awareness across the globe are expected to facilitate the market progression

The DTC genetic testing industry is fragmented in nature with few dominant players and other small start-up companies providing superior quality DTC tests at lower costs that will resolve affordability issues and impact the market growth positively. COVID-19 pandemic positively impacted direct-to-consumer genetic testing market. As, amid pandemic, technology improvements have paved ways for new business opportunities in direct-to-consumer genetic testing. The rapid expansion of the direct-to-consumer genetic testing is aided by the rise in the frequency of chronic diseases and the introduction of personalized testing kits for niche therapeutic areas. Such adaptation and change in services have increased the demand for such kits. Also, availability of these kits on online platform services will also positively influence the market statistics.

Rising demand for personalized direct-to-consumer genetic testing services will boost the market expansion

Increasing demand for personalized direct-to-consumer genetic tests will promote the market growth as customers are willing to pay for the identification and addressing of specific needs. Surging popularity of pharmacogenetics will also positively promote the direct-to-consumer genetic testing industry statistics. As pharmacogenetics is the well-known example of gene-based personalization, where genetic polymorphisms dictate the selection of medicinal treatment that favors the business momentum. Moreover, the evaluation and regulation of personalized tests are based on consumers understanding. The service provider offers descriptive information regarding analytical validity, and clinical validity of the tests that surges its industry demand.
Further, these personalized tests are less expensive than the traditional genetic tests. Also, with simple and noninvasive methods, results of personalized direct-to-consumer genetic test can be quickly obtained. Such aforementioned factors will propel the overall market share.

Increasing usage of genetic information across the healthcare industry will augment the market progress

Based on test-type, the direct-to-consumer genetic testing market is categorized into ancestry & relationship testing, carrier testing, nutrigenomic testing, predictive testing, and skincare testing. The ancestry & relationship testing segment accounted for around 40% market share in 2021 as in recent years, costs for genetic ancestry tests have dropped that has surged its demand. Also, interest in ancestry tests has grown dramatically in developed nations including the U.S that enhances the segmental momentum.
Ancestry testing is commonly known as genetic genealogy that allow people in knowing their family history from historical documentation. By examining DNA variations, it provides clues of an individuals ancestors among people of similar background. For instance, FamilyTreeDNA provides Family Finder DNA tests to find DNA matches and find family connections. This also helps in comparing DNA to DNA from archeological dig sites in finding ancestry history. As a result, the ancestry & relationship testing are in higher demand that will further augment the overall market size.

Increasing adaption of whole genome sequencing will favor the segmental deman

By technology, the direct-to-consumer genetic testing market is fragmented into whole genome sequencing (WGS), targeted analysis, and single nucleotide polymorphism (SNP) chips. Among them, the whole genome sequencing segment accounted for around USD 212 million revenue size in 2021. Whole genome sequencing is one of the methods for analyzing entire genomes. This technology provides a high-resolution for genomic selection and helps in identifying chromosomal regions associated with genetic effects on different traits.
In addition, it also captures small and large variants, identifies causative variants, and delivers huge volumes of data in a short period of time. Whole genome sequencing is mainly used for detecting various types of diseases, pharmacogenomics and drug trials, family genetic diseases as well as rare tumor types. Such varied applications foster the demand of whole genome sequencing method. Therefore, the above-mentioned aspects will propel the overall market trends.

Growing preference for online platform will accelerate the industry progression

Based on distribution, the direct-to-consumer genetic testing industry is bifurcated into online platforms and over-the-counter. The online platforms segment is projected to witness over 15.5% CAGR through 2028 owing to the growing adoption of healthcare applications and rising internet usage. Moreover, online channels allow customers to browse a wide range of a company’s product offerings. As a result, the ease of conducting business through online platforms will drive the industry landscape

Furthermore, companies selling direct-to-consumer genetic testing kits prefer online channels because they allow them to reach a global customer base that contribute towards the market progression.

Increasing awareness regarding direct-to-consumer genetic tests in North America will stimulate the market outlook

North America industry captured over 39% market share in 2021 and is poised to grow substantially during the forthcoming years. High regional growth in the U.S. and Canada is attributed to rising public awareness related to direct-to-consumer genetic tests. Moreover, increasing use of internet among residencies in dense regions of the country will positively improve the market expansion.

Similarly, streamlined regulatory process in the region will promote the market growth. For instance, Food and Drug Administration streamlines regulations and ensure that tests are analytically and clinically valid without involvement of healthcare mediator. All these factors surge the demand for direct-to-consumer genetic testing.

Innovative strategies undertaken by key market players will upsurge several growth opportunities

Some of the key market players operating in the direct-to-consumer genetic testing industry include 23andMe, Inc., Ancestry, Color Genomics, EasyDNA, Family Tree DNA, Full Genome Corporation Inc., Helix OpCo LLC, Karmagenes SA, Living DNA Ltd., Mapmygenome, Identigene, Pathway genomics, Genesis Healthcare Co., MyHeritage, 24 Genetics, The SkinDNA Company Pty Ltd, DNA Forensics Laboratory Pvt. Ltd., and DNA Diagnostic Center.  These industry participants are implementing various growth strategies with continued innovations and technology improvements to sustain market competition in direct-to-consumer genetic testing market.
Some of the recent industry developments:

  • In April 2019, Living DNA updated its ancestry platform to provide more intuitive results with new features. This launch helped to improve the companys product portfolio.
  • In February 2019, Maymygenome partnered with Lucid Diagnostics to upgrade preventive and personalized cancer care by combining genomics and pathology lab services. This strategic move strengthened the market position of the company.

The direct-to-consumer (DTC) genetic testing market research report include an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2017 to 2028, for the following segments:

By Test Type

  • Carrier Testing
  • Predictive Testing
  • Ancestry & Relationship Testing
  • Nutrigenomic Testing
  • Skincare Testing

By Technology

  • Targeted analysis
  • Single nucleotide polymorphism (SNP) chips
  • Whole Genome Sequencing (WGS)

By Distribution Channel

  • Online platform
  • Over-the-counter

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • Japan
    • China
    • India
    • South Korea
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • UAE

Chapter 1   Methodology

1.1    Methodology

1.2    Market definitions

1.3    Forecast parameters

1.4    Data sources

1.4.1    Secondary

1.4.1.1    Paid sources

1.4.1.2    Unpaid sources

1.4.2    Primary

Chapter 2   Executive Summary

2.1    Direct-to-consumer genetic testing industry 360° synopsis, 2017 – 2028

2.1.1    Business trends

2.1.2    Test type trends

2.1.3    Technology trends

2.1.4    Distribution channel trends

2.1.5    Regional trends

Chapter 3   Direct-to-Consumer Genetic Testing Industry Insights

3.1    Industry segmentation

3.2    Industry landscape, 2017 – 2028

3.3    Industry impact forces

3.3.1    Growth drivers

3.3.1.1    Rising public awareness regarding DTC genetic tests in North America

3.3.1.2    Surging income level in emerging economies

3.3.1.3    Increasing demand for personalized DTC genetic services in North America and Europe

3.3.1.4    Growing incidences of genetic disorders globally

3.3.2    Industry pitfalls & challenges

3.3.2.1    High cost of DTC

3.3.2.2    Defects in the DTC testing

3.4    Growth potential analysis

3.4.1    By test type

3.4.2    By technology

3.4.3    By distribution channel

3.5    COVID-19 impact analysis

3.6    Regulatory landscape

3.7    Porter’s analysis

3.8    Competitive landscape, 2021

3.8.1    Company matrix analysis, 2021

3.9    PESTEL analysis

Chapter 4   Direct-To-Consumer Genetic Testing Market, By Test Type

4.1    Key segment trends

4.2    Carrier testing

4.2.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

4.3    Predictive testing

4.3.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

4.4    Ancestry & relationship testing

4.4.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

4.5    Nutrigenomics testing

4.5.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

4.6    Skincare testing

4.6.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

4.7    Others

4.7.1    Market size, by region, 2017 – 2028 (USD Million, 000’ Units)

Chapter 5   Direct-To-Consumer Genetic Testing Market, By Technology

5.1    Key segment trends

5.2    Targeted analysis

5.2.1    Market size, by region, 2017 – 2028 (USD Million)

5.3    Single nucleotide polymorphism (SNP) chips

5.3.1    Market size, by region, 2017 – 2028 (USD Million)

5.4    Whole genome sequencing (WGS)

5.4.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 6   Direct-To-Consumer Genetic Testing Market, By Distribution Channel

6.1    Key segment trends

6.2    Online platforms

6.2.1    Market size, by region, 2017 – 2028 (USD Million)

6.3    Over-the-counter

6.3.1    Market size, by region, 2017 – 2028 (USD Million)

Chapter 7   Direct-To-Consumer Genetic Testing Market, By Region

7.1    Key regional trends

7.2    North America

7.2.1    Market size, by country, 2017 – 2028 (USD Million, 000’ Units)

7.2.2    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.2.3    Market size, by technology, 2017 – 2028 (USD Million)

7.2.4    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.2.5    U.S.

7.2.5.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.2.5.2    Market size, by technology, 2017 – 2028 (USD Million)

7.2.5.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.2.6    Canada

7.2.6.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.2.6.2    Market size, by technology, 2017 – 2028 (USD Million)

7.2.6.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3    Europe

7.3.1    Market size, by country, 2017 – 2028 (USD Million, 000’ Units)

7.3.2    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.3    Market size, by technology, 2017 – 2028 (USD Million)

7.3.4    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3.5    Germany

7.3.5.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.5.2    Market size, by technology, 2017 – 2028 (USD Million)

7.3.5.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3.6    UK

7.3.6.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.6.2    Market size, by technology, 2017 – 2028 (USD Million)

7.3.6.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3.7    France

7.3.7.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.7.2    Market size, by technology, 2017 – 2028 (USD Million)

7.3.7.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3.8    Italy

7.3.8.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.8.2    Market size, by technology, 2017 – 2028 (USD Million)

7.3.8.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.3.9    Spain

7.3.9.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.3.9.2    Market size, by technology, 2017 – 2028 (USD Million)

7.3.9.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4    Asia Pacific

7.4.1    Market size, by country, 2017 – 2028 (USD Million, 000’ Units)

7.4.2    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.3    Market size, by technology, 2017 – 2028 (USD Million)

7.4.4    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4.5    China

7.4.5.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.5.2    Market size, by technology, 2017 – 2028 (USD Million)

7.4.5.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4.6    Japan

7.4.6.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.6.2    Market size, by technology, 2017 – 2028 (USD Million)

7.4.6.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4.7    India

7.4.7.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.7.2    Market size, by technology, 2017 – 2028 (USD Million)

7.4.7.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4.8    South Korea

7.4.8.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.8.2    Market size, by technology, 2017 – 2028 (USD Million)

7.4.8.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.4.9    Australia

7.4.9.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.4.9.2    Market size, by technology, 2017 – 2028 (USD Million)

7.4.9.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.5    Latin America

7.5.1    Market size, by country, 2017 – 2028 (USD Million, 000’ Units)

7.5.2    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.5.3    Market size, by technology, 2017 – 2028 (USD Million)

7.5.4    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.5.5    Brazil

7.5.5.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.5.5.2    Market size, by technology, 2017 – 2028 (USD Million)

7.5.5.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.5.6    Mexico

7.5.6.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.5.6.2    Market size, by technology, 2017 – 2028 (USD Million)

7.5.6.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.5.7    Argentina

7.5.7.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.5.7.2    Market size, by technology, 2017 – 2028 (USD Million)

7.5.7.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.6    Middle East & Africa

7.6.1    Market size, by country, 2017 – 2028 (USD Million, 000’ Units)

7.6.2    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.6.3    Market size, by technology, 2017 – 2028 (USD Million)

7.6.4    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.6.5    Saudi Arabia

7.6.5.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.6.5.2    Market size, by technology, 2017 – 2028 (USD Million)

7.6.5.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.6.6    South Africa

7.6.6.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.6.6.2    Market size, by technology, 2017 – 2028 (USD Million)

7.6.6.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

7.6.7    UAE

7.6.7.1    Market size, by test type, 2017 – 2028 (USD Million, 000’ Units)

7.6.7.2    Market size, by technology, 2017 – 2028 (USD Million)

7.6.7.3    Market size, by distribution channel, 2017 – 2028 (USD Million)

Chapter 8   Company Profiles

8.1    Strategy dashboard, 2021

8.2    23andMe, Inc.

8.2.1    Business overview

8.2.2    Financial data

8.2.3    Product landscape

8.2.4    Strategic outlook

8.2.5    SWOT analysis

8.3    Ancestry

8.3.1    Business overview

8.3.2    Financial data

8.3.3    Product landscape

8.3.4    Strategic outlook

8.3.5    SWOT analysis

8.4    Color Genomics

8.4.1    Business overview

8.4.2    Financial data

8.4.3    Product landscape

8.4.4    Strategic outlook

8.4.5    SWOT analysis

8.5    Easy DNA

8.5.1    Business overview

8.5.2    Financial data

8.5.3    Product landscape

8.5.4    Strategic outlook

8.5.5    SWOT analysis

8.6    Family Tree DNA

8.6.1    Business overview

8.6.2    Financial data

8.6.3    Product landscape

8.6.4    Strategic outlook

8.6.5    SWOT analysis

8.7    Full Genome Corporation Inc.

8.7.1    Business overview

8.7.2    Financial data

8.7.3    Product landscape

8.7.4    Strategic outlook

8.7.5    SWOT analysis

8.8    Helix OpCo LLC

8.8.1    Business overview

8.8.2    Financial data

8.8.3    Product landscape

8.8.4    Strategic outlook

8.8.5    SWOT analysis

8.9    Karmagenes SA

8.9.1    Business overview

8.9.2    Financial data

8.9.3    Product landscape

8.9.4    Strategic outlook

8.9.5    SWOT analysis

8.10    Living DNA Ltd.

8.10.1    Business overview

8.10.2    Financial data

8.10.3    Product landscape

8.10.4    Strategic outlook

8.10.5    SWOT analysis

8.11    Mapmygenome

8.11.1    Business overview

8.11.2    Financial data

8.11.3    Product landscape

8.11.4    Strategic outlook

8.11.5    SWOT analysis

8.12    Identigene

8.12.1    Business overview

8.12.2    Financial data

8.12.3    Product landscape

8.12.4    Strategic outlook

8.12.5    SWOT analysis

8.13    Pathway genomics

8.13.1    Business overview

8.13.2    Financial data

8.13.3    Product landscape

8.13.4    Strategic outlook

8.13.5    SWOT analysis

8.14    Genesis Healthcare Co.

8.14.1    Business overview

8.14.2    Financial data

8.14.3    Product landscape

8.14.4    Strategic outlook

8.14.5    SWOT analysis

8.15    MyHeritage

8.15.1    Business overview

8.15.2    Financial data

8.15.3    Product landscape

8.15.4    Strategic outlook

8.15.5    SWOT analysis

8.16    24 Genetics

8.16.1    Business overview

8.16.2    Financial data

8.16.3    Product landscape

8.16.4    Strategic outlook

8.16.5    SWOT analysis

8.17    The SkinDNA Company Pty Ltd

8.17.1    Business overview

8.17.2    Financial data

8.17.3    Product landscape

8.17.4    Strategic outlook

8.17.5    SWOT analysis

8.18    DNA Forensics Laboratory Pvt. Ltd.

8.18.1    Business overview

8.18.2    Financial data

8.18.3    Product landscape

8.18.4    Strategic outlook

8.18.5    SWOT analysis

8.19    DNA Diagnostic Center

8.19.1    Business overview

8.19.2    Financial data

8.19.3    Product landscape

8.19.4    Strategic outlook

8.19.5    SWOT analysis

Data Tables

TABLE 1    DTC Genetic Testing market, 2017 – 2021, (USD Million)

TABLE 2    DTC Genetic Testing market, 2022 – 2028, (USD Million)

TABLE 3    DTC Genetic Testing market, 2017 – 2021, (000’ Units)

TABLE 4    DTC Genetic Testing market, 2022 – 2028, (000’ Units)

TABLE 5    DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 6    DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 7    DTC genetic testing market, by test type, 2017 – 2021 (000’ Units)

TABLE 8    DTC genetic testing market, by test type, 2022 – 2028 (000’ Units)

TABLE 9    DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 10    DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 11    DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 12    DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 13    DTC genetic testing market by region, 2017 – 2021 (USD Million)

TABLE 14    DTC genetic testing market by region, 2022 – 2028 (USD Million)

TABLE 15    DTC genetic testing market by region, 2017 – 2021 (000’ Units)

TABLE 16    DTC genetic testing market by region, 2022 – 2028 (000’ Units)

TABLE 17    Industry impact forces

TABLE 18    Carrier testing market by region, 2017 – 2021 (USD Million)

TABLE 19    Carrier testing market by region, 2022 – 2028 (USD Million)

TABLE 20    Carrier testing by region, 2017 – 2021 (000’ Units)

TABLE 21    Carrier testing by region, 2022 – 2028 (000’ Units)

TABLE 22    Predictive testing market by region, 2017 – 2021 (USD Million)

TABLE 23    Predictive testing market by region, 2022 – 2028 (USD Million)

TABLE 24    Predictive testing by region, 2017 – 2021 (000’ Units)

TABLE 25    Predictive testing by region, 2022 – 2028 (000’ Units)

TABLE 26    Ancestry & relationship testing market by region, 2017 – 2021 (USD Million)

TABLE 27    Ancestry & relationship testing market by region, 2022 – 2028 (USD Million)

TABLE 28    Ancestry & relationship testing by region, 2017 – 2021 (000’ Units)

TABLE 29    Ancestry & relationship testing by region, 2022 – 2028 (000’ Units)

TABLE 30    Nutrigenomics testing market by region, 2017 – 2021 (USD Million)

TABLE 31    Nutrigenomics testing market by region, 2022 – 2028 (USD Million)

TABLE 32    Nutrigenomics testing by region, 2017 – 2021 (000’ Units)

TABLE 33    Nutrigenomics testing by region, 2022 – 2028 (000’ Units)

TABLE 34    Skincare testing market by region, 2017 – 2021 (USD Million)

TABLE 35    Skincare testing market by region, 2022 – 2028 (USD Million)

TABLE 36    Skincare testing by region, 2017 – 2021 (000’ Units)

TABLE 37    Skincare testing by region, 2022 – 2028 (000’ Units)

TABLE 38    Others market by region, 2017 – 2021 (USD Million)

TABLE 39    Others market by region, 2022 – 2028 (USD Million)

TABLE 40    Others by region, 2017 – 2021 (000’ Units)

TABLE 41    Others by region, 2022 – 2028 (000’ Units)

TABLE 42    Targeted analysis market by region, 2017 – 2021 (USD Million)

TABLE 43    Targeted analysis market by region, 2022 – 2028 (USD Million)

TABLE 44    Single nucleotide polymorphism market by region, 2017 – 2021 (USD Million)

TABLE 45    Single nucleotide polymorphism market by region, 2022 – 2028 (USD Million)

TABLE 46    Whole genome sequencing market by region, 2017 – 2021 (USD Million)

TABLE 47    Whole genome sequencing market by region, 2022 – 2028 (USD Million)

TABLE 48    Online platforms market by region, 2017 – 2021 (USD Million)

TABLE 49    Online platforms market by region, 2022 – 2028 (USD Million)

TABLE 50    Over the counter market by region, 2017 – 2021 (USD Million)

TABLE 51    Over the counter market by region, 2022 – 2028 (USD Million)

TABLE 52    North America DTC genetic testing market, by country, 2017 – 2021, (USD Million)

TABLE 53    North America DTC genetic testing market, by country, 2022 – 2028, (USD Million)

TABLE 54    North America DTC genetic testing market, by country, 2017 – 2021, (000’ Units)

TABLE 55    North America DTC genetic testing market, by country, 2022 – 2028, (000’ Units)

TABLE 56    North America DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 57    North America DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 58    North America DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 59    North America DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 60    North America DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 61    North America DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 62    North America DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 63    North America DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 64    U.S. DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 65    U.S. DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 66    U.S. DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 67    U.S. DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 68    U.S. DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 69    U.S. DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 70    U.S. DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 71    U.S. DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 72    Canada DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 73    Canada DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 74    Canada DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 75    Canada DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 76    Canada DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 77    Canada DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 78    Canada DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 79    Canada DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 80    Europe DTC genetic testing market, by country, 2017 – 2021, (USD Million)

TABLE 81    Europe DTC genetic testing market, by country, 2022 – 2028, (USD Million)

TABLE 82    Europe DTC genetic testing market, by country, 2017 – 2021, (000’ Units)

TABLE 83    Europe DTC genetic testing market, by country, 2022 – 2028, (000’ Units)

TABLE 84    Europe DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 85    Europe DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 86    Europe DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 87    Europe DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 88    Europe DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 89    Europe DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 90    Europe DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 91    Europe DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 92    Germany DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 93    Germany DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 94    Germany DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 95    Germany DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 96    Germany DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 97    Germany DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 98    Germany DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 99    Germany DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 100    UK DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 101    UK DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 102    UK DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 103    UK DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 104    UK DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 105    UK DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 106    UK DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 107    UK DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 108    France DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 109    France DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 110    France DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 111    France DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 112    France DTC genetic testing market, by technology, 2017 – 2021, (USD Million)

TABLE 113    France DTC genetic testing market, by technology, 2022 – 2028, (USD Million)

TABLE 114    France DTC genetic testing market, by distribution channel, 2017 – 2021, (USD Million)

TABLE 115    France DTC genetic testing market, by distribution channel, 2022 – 2028, (USD Million)

TABLE 116    Italy DTC genetic testing market, by test type, 2017 – 2021, (USD Million)

TABLE 117    Italy DTC genetic testing market, by test type, 2022 – 2028, (USD Million)

TABLE 118    Italy DTC genetic testing market, by test type, 2017 – 2021, (000’ Units)

TABLE 119    Italy DTC genetic testing market, by test type, 2022 – 2028, (000’ Units)

TABLE 120    Italy DTC genetic testing mar

By Test Type

  • Carrier Testing
  • Predictive Testing
  • Ancestry & Relationship Testing
  • Nutrigenomic Testing
  • Skincare Testing

By Technology

  • Targeted analysis
  • Single nucleotide polymorphism (SNP) chips
  • Whole Genome Sequencing (WGS)

By Distribution Channel

  • Online platform
  • Over-the-counter

23andMe, Inc., Ancestry, Color Genomics, EasyDNA, Family Tree DNA, Full Genome Corporation Inc., Helix OpCo LLC, Karmagenes SA, Living DNA Ltd., Mapmygenome, Identigene, Pathway genomics, Genesis Healthcare Co., MyHeritage, 24 Genetics, The SkinDNA Company Pty Ltd, DNA Forensics Laboratory Pvt. Ltd., and DNA Diagnostic Center.

Why Choose MWR

Quality Research

Our goal is to provide high-quality data that stimulates growth and creates a win-win situations

Unlimited User Access 

We offer Corporate User license access on all our reports in which you can share the report with your entire team without any restrictions

Free Company Inclusion 

We give you an option to include 3-4 additional company players of your choice in our report without any extra charges

Post Sale Assistance

Unlimited post sales service with an account manager dedicated to making sure that all your needs are met

Covid-19 Impact Analysis

All our research report includes latest Covid-19 Impact and its analysis

Download Free Sample PDF

444 Alaska Avenue

Suite #BAA205 Torrance, CA 90503 USA

+1 424 360 2221

24/7 Customer Support

Download Free Sample PDF